- Research and Development Strategies
- Genentech and Renovis collaborate on protein therapeutics
- Abgenix, AstraZeneca develop monoclonal antibodies for cancer
- Evotec, Takeda in Alzheimer's disease deal
- Tularik, Amgen discover and develop cancer therapeutics
- Amgen acquires Tularik in $1.3bn stock swap
- Cardiome enters $68mm anti-arrhythmic deal with Fujisawa; ends
- Merck gets ex- N. American rights to Cardiome's oral vernakalant; later gains WW rights; deal ends
- Pfizer, Akzo Nobel's Organon develop antipsychotic drug
- BMS, QDose end inhaled insulin product deal
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.